New funding from the Scottish National Investment Bank and the Investment Fund for Scotland to support tooth decay detection technology. Investment will help medical device go to market after becoming the first produced in Scotland to secure FDA premarket approval in the United States. Calcivis has secured £5m in funding to roll out its cutting-edge dental technology. The firm’s patented system enables early detection of tooth decay – which in turn can enable timely preventive treatment – by deploying a biologic diagnostic agent in combination with an imaging device. Calcivis aims ..read more

Archangels Team (L-R):      Niki McKenzie, David Ovens, Dan McKiddie, Sarah Hardy and Shaolei McKie   (Photography by Jamie Williamson jamiewilliamson.com) Archangels, invested more than £13.8m during 2023 in eleven of Scotland’s best early-stage tech and life science companies. The total investment for 2023 among 11 businesses represents a small increase on Archangels’ investment activity in 2022 (£13.4m). The year saw Archangels make two new investments including Bioliberty who secured £2.2M to fund the development of its soft robotic glove and, more recently ..read more

1nhaler (L-R) Khadija Schwach, Don Smith, Lisa McMyn and Helen Muirhead | Photography by jamiewilliamson.com @jwilliamsonpix 1nhaler, a Scotland-based drug delivery device developer, has raised £2 million to develop its unique single-use dry powder inhaler (DPI). Inhalable medicines are already widely used to treat conditions such as asthma, epilepsy, allergies and Parkinson’s but, to date, delivery options have been limited due to user accessibility, cost, performance and impact on the environment. 1nhaler has developed a way of enabling many different dry powder drugs to be readily del ..read more

Cytomos, Roślin, Midlothian | Photograph: mike-wilkinson.com   Archangels, Cytomos, an Edinburgh-based life science company that has developed a proprietary new approach to analysing cells, has secured £4 million to scale up market-testing of its technology platform Cytomos Dielectric Spectroscopy (CDS). The investment round was led by existing investors Archangels with participation from Old College Capital, Scottish Enterprise and new investor British Business Bank. Cytomos has developed CDS to address the unmet needs of the biopharma industry, providing a groundbreaking hi ..read more

Archangels’ Team (L-R) : Niki McKenzie, Joint MD; David Ovens, Joint MD; Dan McKiddie, Investment Manager; Sarah Hardy, Director and Head of New Investments; Shaolei McKie, Senior Investment Manager. | Photography by Jamie Williamson jamiewilliamson.com   Archangels, a leading business angel syndicate investing in early-stage Scottish life sciences and technology companies, is bolstering its funding fire power after securing a £12m co-investment agreement with British Business Investments via its Regional Angels Programme. The deal will provide the Edinburgh-based syndicate with addit ..read more

Dan McKiddie, Investment Manager | Photography by Jamie Williamson jamiewilliamson.com   Archangels, has appointed Daniel McKiddie as investment manager to join its executive team, led by joint Managing Directors Niki McKenzie and David Ovens. Archangels has recruited McKiddie, a chartered accountant, to work alongside Senior Investment Manager, Shaolei McKie in managing analysis, fundraising support and exit strategies for its investment portfolio of Scottish life sciences and technology businesses. After studying mechanical engineering at Glasgow University, Daniel McKiddie spent ei ..read more

Professor Adam Stokes, Archangels Academic in Residence | Photocredit: Stewart Attwood Photography   Archangels, has appointed Professor Adam Stokes as its Academic in Residence. Professor Stokes, Co-Lead of The National Robotarium and Deputy Director of the Edinburgh Centre for Robotics, will help Archangels review investment opportunities from Scotland’s most exciting life sciences and technology businesses. As well as a successful academic career, Professor Stokes is also the founder of several businesses in the health-tech and robotics space and consults on a variety of other ve ..read more

Bioliberty (L-R): Conan Bradley, Chief Design Officer; Rowan Armstrong, CEO; Ross O’Hanlon, CTO and Shéa Quinn, COO with Niki McKenzie, Joint MD at Archangels | Photocredit: jamiewilliamson.com Scottish technology firm Bioliberty has secured £2.2 million in funding to develop a unique soft robotic glove which can restore upper limb mobility in patients following a stroke. The funding round was led by Archangels, with participation from Eos Advisory, Old College Capital and Hanna Capital SEZC. The Edinburgh-based business has created the Lifeglov – a soft robotic glove which offer ..read more

Dental imaging technology company Calcivis is setting its sights on US growth having secured pre-market approval (PMA) from the US Food and Drug Administration (FDA). As the first Scottish medical device to secure the coveted accreditation, the Calcivis Imaging System aims to revolutionise the dental sector by enabling the move to a more preventive treatment model. PMA approval is only awarded after a statutory process of scientific review to ensure the efficacy and safety of medical devices. PMA accreditation will allow Edinburgh-based Calcivis to tap into the multi-billion dollar US dental ..read more

David Ovens, Ian MacLeod and Niki McKenzie | Photo credit: Jamie Williamson –  jamiewilliamson.com Archangels invested £13.4m during 2022 in some of Scotland’s most promising early-stage tech and life science companies.  The total investment for 2022 among 11 businesses marks a 14% increase on Archangels’ investment activity in 2021 (11.8m). New additions to the portfolio included tech firm Earth Blox who secured £1.5m funding from Archangels to expand its global reach and further develop its no-code Earth Observation (EO) cloud-based SaaS. Other businesses to receive follow-on fu ..read more